Osaic Holdings’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
Other funds holding OVID
Osaic Holdings's OVID Position: Q3 2026 in Review
Osaic Holdings held its Ovid Therapeutics (OVID) position steady in Q3 2026 at 306 shares worth $777. The position accounts for ﹤0.01% of the portfolio, ranked #7611.
Osaic Holdings first reported a position in OVID in Q2 2020 and has held it in 24 quarters since. The position peaked at $6K in Q2 2020. 129 funds tracked by Wall St. Rank hold OVID as of Q3 2026.
- Osaic Holdings held 306 shares of Ovid Therapeutics worth $777 as of Q3 2026.
- Osaic Holdings left its Ovid Therapeutics share count unchanged in Q3 2026.
- Ovid Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q3 2026, its #7611 holding.
- Osaic Holdings first reported a position in Ovid Therapeutics in Q2 2020 and has held it in 24 quarters since.
- Osaic Holdings's Ovid Therapeutics position peaked at $6K in Q2 2020.
- 129 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q3 2026.
Based on Osaic Holdings's 13F filing for Q3 2026, filed 12 Nov 2026.